Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Therapeutic potential of AAE-581 seen in postmenopausal women

June 7, 2006

Ostabolin-C demonstrates effects on bone in rats

June 7, 2006

Partnership to test encapsulated human islets in phase I/II trial

June 7, 2006

Target enrollment completed in phase IIa study of E1-I.N.T. in type 1 diabetes

June 6, 2006

Orphan drug status for ISIS-301012 in homozygous familial hypercholesterolemia

June 2, 2006

International study to test new drug combination to cut cardiovascular disease

June 2, 2006

European orphan medicinal product status for Increlex for primary IGFD

June 2, 2006

Icagen studies ICA-17043 in pediatric sickle cell disease patients

June 2, 2006

Astellas returns Japanese strontium ranelate rights to Servier

May 31, 2006

Agents with potential for the treatment of metabolic disorders described in recent patents

May 31, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...